Recent advances in the oral delivery of insulin

Recent Patents on Drug Delivery and Formulation

Volumn 8, Issue 2, 2014, Pages 155-159

  Ramesan, Rekha M ^a   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Diabetes; Microparticle; Nanoparticle; Oral insulin; Permeation enhancement

Indexed keywords

ENZYME INHIBITOR; EUDRAGIT; INSULIN; NANOCARRIER; PENETRATION ENHANCING AGENT; POLYMER; ANTIDIABETIC AGENT;

DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTOXICITY; GLUCOSE BLOOD LEVEL; HUMAN; MUCOADHESION; NONHUMAN; ORAL DRUG DELIVERY SYSTEM; PATENT; PH; PHYSICAL PARAMETERS; PRIORITY JOURNAL; REVIEW; STOMACH PH; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATENTS AS TOPIC;

EID: 84904750567     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872211308666140527143407     Document Type: Review

References (26)

1. Diabetes Atlas, 5 th Edition. International Diabetes Federation, 2012.
2. Feskens EJ, Kromhout D. Hyperinsulinemia, risk factors, and coronary heart disease. The zutphen elderly study. Arterioscler Thromb 1994; 14: 1641-7.
3. Woodley F. Enzymatic barriers for Gl peptide and protein delivery. Crit Rev Ther Drug 1994; 11: 61-95.
4. Zhou XH. Overcoming enzymatic and absorption barriers to nonparenterally administered protein and peptide drugs. J Control Release 1994; 29: 239-52.
5. Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 2007; 117: 271-80.
6. Damge C, Pinto C, Maincent P. Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv 2008; 5: 45-68.
7. Kim B, Peppas NA. Poly (ethylene glycol)-containing Hydrogels as insulin delivery carriers. AAPS Pharm Sci 2000; S2394.
8. Morishita M, Goto T, Peppas NA, et al. Mucosal insulin delivery systems based on complexation polymer hydrogels: Effect of particle size on insulin enteral absorption. J Control Release 2004; 97: 115-24.
9. Bernkop-Schnurch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 2001; 71: 277-85.
10. Rekha MR, Sharma CP. Phthalyl chitosan-poly (ethylene oxide) semi-interpenetrating polymer network microparticles for oral protein delivery: An in vitrocharacterization. J App Pol Sci 2008; 110: 2787-95.
11. Rekha MR, Sharma CP. Challenges and advances in nanoparticlebased oral insulin delivery. Expert Rev Med Devices 2009; 6: 665-76.
12. Woodley JF. Peptidase activity in the G. I. tract: Distribution between luminal contents and mucosal tissue. Proc Int Symp Control Release Bioact Mater 1991; 18: 337-8.
13. Ikesue K, Kopeckova P, Kopecek J. Degradation of proteins by guinea pig intestinal enzymes. Int J Pharm 1993; 95: 171-9.
14. Smith JC, Wilson FD, Allen PV, Berry D L. Hypertrophy and hyperplasia of the rat pancreas produced by short-term dietary administration of soya-derived protein and soybean trypsin inhibitor. J Appl Toxicol 1989; 9: 175-9.
15. Bernkop-Schnuch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 1998; 52: 1-16.
16. Kotzé AF, Lueßen HL, de Leeuw BJ, de Boer AG, Verhoef JC, Junginger HE. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998; 51: 35-46.
17. Sharma, C. P., Rekha, M. R. ph sensitive nanoparticle formulation for oral delivery of proteins/peptides. WO2007032018A1 (2007).
18. Zhang, L., Ling, L., Zhou, L. Y., Wu, Z. M., Guo, X. D., Qian, L., Jiang, W., Luo, Q. pH-sensitive nanoparticles for oral insulin delivery. US20130034589A1 (2013).
19. Qian, Y., Zhang, L., Wu, Z. M., Zhou, L. Y., Jiang, W., Ling, L., Lou, Q., Guo, D. ZX. Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery US20130034602A1 (2013).
20. Gribova, O., Vol, A. Methods and compositions for oral administration of insulin. EP2254590B1 (2012).
21. Vidhya, R., Tejrar, M. A., Vadde, R. B., Raghavendra, C. M., Anand, H. Oral insulin delivery systems for controlling diabetes. WO2010113177A2 (2010).
22. Lowman, A. M., Morishita, M., Nagai, T., Peppas, N. A. Method for oral delivery of proteins. EP0975328A1 (2000).
23. Arbit, E., Goldberg, M., Majuru, S. Oral insulin therapies and protocol. US8324156 B2 (2012)
24. Kidron, M., Arbut, E. Methods and compositions for oral administration of proteins. US20110142800A1 (2011).
25. Ekwuribe, N. N., Price, C. H., Still, J. G., Filbey, J. A., Ansari, A. M., Odenbaugh, A. L., Radhakrishnan, B. Insulin conjugates for treating diabetes mellitus US7423014B2 (2008).
26. Ekwuribe, N. N., Price, C. H., Still, J. G., Filbey, J. A. Methods of treating diabetes mellitus. US7060675 (2006).